Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjogren's syndrome

被引:59
|
作者
Hansen, A
Reiter, K
Ziprian, T
Jacobi, A
Hoffmann, A
Gosemann, M
Scholze, J
Lipsky, PE
Dörner, T
机构
[1] Univ Hosp Charite, Dept Med, Outpatient Dept, D-10098 Berlin, Germany
[2] NIAMSD, NIH, Bethesda, MD 20892 USA
来源
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 07期
关键词
D O I
10.1002/art.21129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess whether abnormal chemokine receptor expression and/or abnormal responsiveness to the cognate ligands might underlie some of the disturbances in B cell homeostasis characteristic of primary Sjogren's syndrome (SS). Methods. Chemokine receptor expression by CD27- naive and CD27+ -memory B cells from patients with primary SS and healthy control subjects was analyzed using flow cytometry, single-cell reverse transcriptase-polymerase chain reaction (RT-PCR), and migration assays. Results. In contrast to healthy subjects, significantly higher expression of both surface CXCR4 and CXCR4 messenger RNA (mRNA) was seen in peripheral blood B cells from patients with primary SS. These differences were most prominent in CD27- naive B cells (P <= 0.0006). In addition, significantly higher frequencies of CD27- naive B cells from patients with primary SS expressed mRNA for the inhibitory regulator of G protein signaling 13 (P = 0.001). Expression of CXCR5 by peripheral CD27+ memory B cells was moderately diminished in patients with primary SS compared with healthy controls (P = 0.038). No significant differences were noted in the expression of CXCR3, CCR6, CCR7, and CCR9 between B cells from healthy controls and those from patients with primary SS. Transmigration assays of blood B cells from patients with primary SS and healthy controls showed comparable responses of CD27- naive B cells but significantly diminished responses of activated primary SS CD27+ memory B cells to the ligands of CXCR4 and CXCR5, CXCL12 (P = 0.032), and CXCL13 (B lymphocyte chemoattractant; B cell-attracting chemokine 1; P = 0.018), respectively, when compared with those from healthy controls. Finally, compared with controls, peripheral reduction but glandular accumulation of CXCR4+,CXCR5+,CD27+ memory B cells was identified in patients with primary SS. Conclusion. In primary SS, overexpression of CXCR4 by circulating blood B cells does not translate into enhanced migratory response to the cognate ligand, CXCL12. This migratory response may be modulated by intracellular regulators. Retention of CXCR4+,CXCR5+, CD27+ memory B cells in the inflamed glands seems to contribute to diminished peripheral CD27+ memory B cells in primary SS.
引用
收藏
页码:2109 / 2119
页数:11
相关论文
共 50 条
  • [31] BAFF-production and BAFF-receptor expression by B-cells in salivary glands from patients with primary Sjogren's syndrome.
    Daridon, Capucine
    Devauchelle-Pensec, Valerie
    Hutin, Pascal
    Saraux, Alain
    Youinou, Pierre
    Pers, Jacques-Olivier
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S706 - S706
  • [32] Clinical significance of chemokine expression in the minor salivary glands of patients with Sjogren's syndrome
    Lee, Kyung-Eun
    Kang, Ji-Hyoun
    Park, Dong-Jin
    Yoon, Kyung Chul
    Lee, Ji Shin
    Lee, Shin-Seok
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S295 - S295
  • [33] The Important Role of T Cells and Receptor Expression in Sjogren's Syndrome
    Karabiyik, A.
    Peck, A. B.
    Nguyen, C. Q.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 78 (02) : 157 - 166
  • [34] B cells in the pathogenesis of primary Sjogren syndrome
    Nocturne, Gaetane
    Mariette, Xavier
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (03) : 133 - 145
  • [35] Low number of memory B cells in the salivary glands of patients with primary Sjogren's syndrome
    Aqrawi, Lara A.
    Brokstad, Karl A.
    Jakobsen, Kjerstin
    Jonsson, Roland
    Skarstein, Kathrine
    AUTOIMMUNITY, 2012, 45 (07) : 547 - 555
  • [36] Analysis of VHDJH rearrangements.in individual B cells of patients with primary Sjogren's syndrome
    Hansen, A
    Reiter, K
    Gosemann, M
    Lipsky, PE
    Burmester, GR
    Dörner, T
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 236 - 236
  • [37] Skin Barrier Function in Patients with Primary and Secondary Sjogren's Syndrome
    Olewicz-Gawlik, Anna
    Polanska, Adriana
    Trzybulska, Dorota
    Nowak-Gabryel, Michalina
    Blochowiak, Katarzyna
    Kociecki, Jaroslaw
    Sokalski, Jerzy
    Zaba, Ryszard
    Adamski, Zygmunt
    Danczak-Pazdrowska, Aleksandra
    ACTA DERMATOVENEROLOGICA CROATICA, 2018, 26 (02) : 153 - 156
  • [38] Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with primary Sjogren's syndrome.
    Manoussakis, MN
    Dimitriou, I
    Kapsogeorgou, E
    Polihronis, M
    Xanthou, G
    Moutsopoulos, HM
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1167 - 1167
  • [39] Chemokine tear levels in primary Sjogren's syndrome and their relationship with symptoms
    Hernandez-Molina, Gabriela
    Ruiz-Quintero, Narlly
    Lima, Guadalupe
    Hernandez-Ramirez, Diego
    Llorente-Chavez, Amaya
    Saavedra-Gonzalez, Vanessa
    Jimenez-Soto, Rodolfo
    Llorente, Luis
    INTERNATIONAL OPHTHALMOLOGY, 2022, 42 (08) : 2355 - 2361
  • [40] NOT ALL SJOGREN IS DRY - PRESERVED GLANDULAR FUNCTION IN A SUBGROUP OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME
    Lackner, A.
    Zenz, S.
    Hermann, J.
    Thiel, J.
    Stradner, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1492 - 1492